Cytosorbents Corp (CTSO) › Operating IncomeCytosorbents Corp (CTSO) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2010: -$2.82M2011: -$4.44M2012: -$3.49M2013: -$4.71M2014: -$6.89M2015: -$9.30M2016: -$11.49M2017: -$9.84M2018: -$15.58M2019: -$18.97M2020: -$10.37M2021: -$22.74M2022: -$31.52M2023: -$31.95M2024: -$16.45M2025: -$14.75M-$14.75M2010Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$14.75M+10.4%2024-$16.45M+48.5%2023-$31.95M-1.4%2022-$31.52M-38.6%2021-$22.74M-119.3%2020-$10.37M+45.3%2019-$18.97M-21.7%2018-$15.58M-58.3%2017-$9.84M+14.4%2016-$11.49M-23.5%2015-$9.30M-35.0%2014-$6.89M-46.2%2013-$4.71M-35.0%2012-$3.49M+21.3%2011-$4.44M-57.1%2010-$2.82M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share